Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDP.L Regulatory News (IDP)

  • There is currently no data for IDP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - INNOVADERMA PLC

15 Feb 2021 12:22

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a)Full name of discloser:Barclays PLC.
 
(b)Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c)Name of offeror/offeree in relation to whoseINNOVADERMA PLC
relevant securities this form relates:
(d)If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e)Date position held/dealing undertaken:

12 February 2021

(f)In addition to the company in 1(c) above, is the discloser makingNO
disclosures in respect of any other party to the offer?

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:0.10 EUR ordinary
InterestsShort Positions
Number(%)Number(%)

(1)

Relevant securities owned
and/or controlled:

471,965

3.26%

0

0.00%

 

(2)

Cash-settled derivatives:

0

0.00%

471,965

3.26%

 

(3)

Stock-settled derivatives (including options)
and agreements to purchase/sell:

0

0.00%

0

0.00%

 
 
TOTAL:

471,965

3.26%

471,965

3.26%

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevantPurchase/saleNumber ofPrice per unit
securitysecurities

0.10 EUR ordinary

Sale

10,000

0.4700 GBP

(b) Cash-settled derivative transactions

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

 

reference

unit

security

 

 

securities

0.10 EUR ordinary

SWAP

Long

10,000

0.4700 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

15 Feb 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210215005188/en/

Copyright Business Wire 2021

Date   Source Headline
8th Mar 201810:13 amRNSTrading Statement
15th Feb 20187:00 amRNSHalf-year Report
2nd Feb 20187:00 amRNSDirector/PDMR Shareholding
16th Jan 20187:00 amRNSTrading Statement
15th Dec 20177:00 amRNSIssue of Warrants and Issue of Equity
24th Nov 201711:37 amRNSHolding(s) in Company
10th Nov 20177:00 amRNSAllotment of Shares
8th Nov 201710:47 amRNSResult of AGM
8th Nov 20177:00 amRNSAGM Statement and Operational Update
7th Nov 20178:16 amRNSHolding(s) in Company
20th Oct 20177:53 amRNSAllotment of Shares
18th Oct 20179:52 amRNSASA Ruling
16th Oct 20177:00 amRNSHolding(s) in Company
16th Oct 20177:00 amRNSAdmission of Shares
12th Oct 20175:18 pmRNSNotice of AGM & Posting of Annual Report
12th Oct 201710:40 amRNSHolding(s) in Company
9th Oct 20177:00 amRNSTotal Voting Rights
6th Oct 20179:55 amRNSCompletion of Placing
6th Oct 20177:00 amRNSProposed Placing
2nd Oct 20177:00 amRNSAllotment of Shares
27th Sep 20177:00 amRNSOperational Update
14th Sep 20177:00 amRNSTransfer of Shares
12th Sep 20177:00 amRNSFinal Results
4th Sep 20177:00 amRNSOperational Update
11th Aug 20179:30 amRNSNotice of Results
28th Jul 201711:58 amRNSDirector/PDMR Shareholding
26th Jul 20172:22 pmRNSAllotment of Shares
26th Jul 20177:00 amRNSOperational Update
26th Jul 20177:00 amRNSDirectorate Change and Change Of Adviser
19th Jun 20174:40 pmRNSSecond Price Monitoring Extn
19th Jun 20174:35 pmRNSPrice Monitoring Extension
19th Jun 20172:05 pmRNSSecond Price Monitoring Extn
19th Jun 20172:00 pmRNSPrice Monitoring Extension
19th Jun 201711:05 amRNSSecond Price Monitoring Extn
19th Jun 201711:00 amRNSPrice Monitoring Extension
19th Jun 20179:05 amRNSSecond Price Monitoring Extn
19th Jun 20179:00 amRNSPrice Monitoring Extension
19th Jun 20178:18 amRNSTrading Statement (Replacement)
19th Jun 20177:00 amRNSTrading Statement
8th Jun 20177:00 amRNSExercise of Broker Warrants
1st Jun 20177:00 amRNSInnovaDerma secures Boots Ireland
22nd May 20172:05 pmRNSSecond Price Monitoring Extn
22nd May 20172:00 pmRNSPrice Monitoring Extension
22nd May 20177:00 amRNSLaunch of haircare range and entry into skincare
15th May 20179:47 amRNSHolding(s) in Company
10th May 20172:25 pmRNSHolding(s) in Company
10th May 20172:21 pmRNSHolding(s) in Company
8th May 20173:54 pmRNSAllotment of Shares
5th May 20174:40 pmRNSSecond Price Monitoring Extn
5th May 20174:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.